Company news
Guobang Pharma Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on Wholly-owned Subsidiary Receiving Notice of Approval for Marketing Application of Chemical APIs
February 27, 2025
Announcement on Completion and Implementation Results of Repurchase
January 24, 2025
Announcement on Extension of Share Lockup Period by Controlling Shareholder, Actual Controller and Other Shareholders
January 21, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
January 2, 2025
Announcement on the Passing of U.S. FDA On-site Inspection of Florfenicol, a Wholly-owned Subsidiary's Product
December 19, 2024
Announcement on the Progress of Providing Guarantees for Subsidiary
December 8, 2024
Announcement on the Results of Shareholding Reduction by Shareholders
November 29, 2024